Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina Matteo

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Advanced Healthcare Materials|June 18, 2020
Electrostatic Intraperitoneal Aerosol Delivery of Nanoparticles: Proof of Concept and Preclinical ValidationLeen Van de Sande, Mohammad Rahimi-Gorji, Silvia Giordano, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 4, 2024
A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic miceMaria Laura De Angelis, Federica Francescangeli, Eleonora Aricò, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 24, 2019
A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cellsIsabella Orienti, Valentina Salvati, Giovanni Sette, et al.
Pharmaceutics|July 30, 2025
Pharmacokinetics of Pegaspargase with a Limited Sampling Strategy for Asparaginase Activity Monitoring in Children with Acute Lymphoblastic LeukemiaCristina Matteo, Antonella Colombini, Marta Cancelliere, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2026
Rational adjustment of dose to reduce adverse reactions (RADAR) in patients with platinum-sensitive recurrent ovarian cancer: Results from the phase II NEWTON trial (ENGOT-ov49)Nicoletta Colombo, Gabriella Parma, Giulia Tasca, et al.
Therapeutic Advances in Medical Oncology|July 5, 2022
A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT)Charlotte I Stroes, Sandor Schokker, Mohammed Khurshed, et al.
Haematologica|February 2, 2019
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 studyCarmelo Rizzari, Claudia Lanvers-Kaminsky, Maria Grazia Valsecchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2023
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized StudyValentino Conter, Maria Grazia Valsecchi, Gunnar Cario, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Advanced Healthcare Materials|June 18, 2020
Electrostatic Intraperitoneal Aerosol Delivery of Nanoparticles: Proof of Concept and Preclinical ValidationLeen Van de Sande, Mohammad Rahimi-Gorji, Silvia Giordano, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 4, 2024
A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic miceMaria Laura De Angelis, Federica Francescangeli, Eleonora Aricò, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 24, 2019
A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cellsIsabella Orienti, Valentina Salvati, Giovanni Sette, et al.
Pharmaceutics|July 30, 2025
Pharmacokinetics of Pegaspargase with a Limited Sampling Strategy for Asparaginase Activity Monitoring in Children with Acute Lymphoblastic LeukemiaCristina Matteo, Antonella Colombini, Marta Cancelliere, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2026
Rational adjustment of dose to reduce adverse reactions (RADAR) in patients with platinum-sensitive recurrent ovarian cancer: Results from the phase II NEWTON trial (ENGOT-ov49)Nicoletta Colombo, Gabriella Parma, Giulia Tasca, et al.
Therapeutic Advances in Medical Oncology|July 5, 2022
A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT)Charlotte I Stroes, Sandor Schokker, Mohammed Khurshed, et al.
Haematologica|February 2, 2019
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 studyCarmelo Rizzari, Claudia Lanvers-Kaminsky, Maria Grazia Valsecchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2023
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized StudyValentino Conter, Maria Grazia Valsecchi, Gunnar Cario, et al.
Pageof 3